Thomas Stricker, MD
OneOncology, headquartered in Nashville, recently appointed Thomas Stricker, MD, as Medical Director for Precision Medicine. Dr. Stricker will work with partner practices to create workflows that reduce physicians’ burden of genomic test ordering and interpretation, allowing more time for patients. OneOncology is a national platform for independent oncology practices.
Dr. Stricker says he sees three pillars of assistance for testing that he and his team can provide to physician partners:
- At order, to make sure the right tests are ordered
- At initial result, to make sure that the appropriate therapy is given based on the current data
- At disease recurrence or progression, to identify additional options whether they are the standard of care or a clinical trial option.
“The complexity of pathology standards in oncology necessitates a change in the way that results are delivered, such as comprehensive reports that summarize the key data from multiple tests,” Dr. Stricker said. “I am excited to help build systems that can empower our physicians to maximize the value of testing during each stage.”
Strong Background in Genomic Sequencing
Dr. Stricker was most recently Assistant Professor in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University in Nashville, where he founded the Somatic Clinical Sign-out Team and the Clinical Genomics Lab, which generates whole-exome and other germline sequencing panels.
At Vanderbilt University Medical Center, Dr. Stricker also served on molecular tumor boards and was on the team that founded GENIE, an American Association for Cancer Research initiative for the sharing of genomic cancer sequencing data across institutions. He was Assistant Director of VANTAGE, a genomics core laboratory consolidation program with the overall goal of creating a new collaborative shared resource that accelerated discovery in genome sciences and personalized medicine.
Dr. Stricker earned his MD and PhD from Washington University in St. Louis. Following a residency in anatomic pathology and a fellowship in bone and soft tissue at the University of Chicago, he joined the lab of Kevin White, PhD, as a postdoctoral fellow in the Institute for Genomics and Systems Biology.
